FR1586125A - - Google Patents

Info

Publication number
FR1586125A
FR1586125A FR1586125DA FR1586125A FR 1586125 A FR1586125 A FR 1586125A FR 1586125D A FR1586125D A FR 1586125DA FR 1586125 A FR1586125 A FR 1586125A
Authority
FR
France
Prior art keywords
silver
heavy metal
july
compositions
metal salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR1586125A publication Critical patent/FR1586125A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR1586125D 1967-07-17 1968-07-16 Expired FR1586125A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65383067A 1967-07-17 1967-07-17

Publications (1)

Publication Number Publication Date
FR1586125A true FR1586125A (fr) 1970-02-13

Family

ID=24622450

Family Applications (2)

Application Number Title Priority Date Filing Date
FR1586125D Expired FR1586125A (fr) 1967-07-17 1968-07-16
FR169591A Expired FR8146M (fr) 1967-07-17 1968-10-11

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR169591A Expired FR8146M (fr) 1967-07-17 1968-10-11

Country Status (8)

Country Link
BE (1) BE718183A (fr)
DE (1) DE1792053B1 (fr)
ES (1) ES356142A1 (fr)
FR (2) FR1586125A (fr)
GB (2) GB1240545A (fr)
IE (1) IE32197B1 (fr)
NL (1) NL6809794A (fr)
PH (1) PH10639A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2424740A1 (fr) * 1978-02-06 1979-11-30 Fresenius Chem Pharm Ind Sels metalliques de sulfadiazine en fines particules, leur procede de preparation et preparations pharmaceutiques les contenant

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049802A (en) 1975-03-19 1977-09-20 Research Corporation Zinc sulfadiazine and its use in the treatment of burns
US4384117A (en) * 1980-03-18 1983-05-17 The United States Of America As Represented By The Secretary Of The Army Silver metachloridine
AU1388388A (en) * 1987-04-01 1988-10-06 Dak-Laboratoriet A/S Benzoic acid derivatives and use thereof
CA2024220A1 (fr) * 1990-08-29 1992-03-01 Don Simmons Compose contenant de la sulfadiazine d'argent et de la benzocaine pour le traitement des plaies apres une chirurgie au laser
IT1243435B (it) * 1990-10-05 1994-06-10 Altergon Sa Composizioni farmaceutiche per uso topico comprendenti acido ialuronico sale sodico e sostanze disinfettanti
RS44204A (en) 2001-11-22 2007-06-04 Biovitrum Ab., Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
AU2004240885A1 (en) * 2003-05-21 2004-12-02 Biovitrum Ab Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I
US7173030B2 (en) 2003-05-21 2007-02-06 Biovitrum Ab Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
SE0301888D0 (sv) * 2003-06-25 2003-06-25 Biovitrum Ab New use VII
SE0301886D0 (sv) * 2003-06-25 2003-06-25 Biovitrum Ab New use V
SE0301884D0 (sv) * 2003-06-25 2003-06-25 Biovitrum Ab New use III
SE0301885D0 (sv) * 2003-06-25 2003-06-25 Biovitrum Ab New use IV
SE0301882D0 (sv) * 2003-06-25 2003-06-25 Biovitrum Ab New use I
WO2004113310A1 (fr) * 2003-06-25 2004-12-29 Biovitrum Ab Utilisation d'un inhibiteur de compose de type 1 11-b-hydroxysteroide deshydrogenase type 1 destine a faciliter la cicatrisation d'une plaie
BRPI1104620B1 (pt) * 2011-09-09 2020-04-07 Lucia Teixeira De Carvalho composição farmacêutica para tratamento de queimaduras e lesões da pele e seu processo de preparação

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2424740A1 (fr) * 1978-02-06 1979-11-30 Fresenius Chem Pharm Ind Sels metalliques de sulfadiazine en fines particules, leur procede de preparation et preparations pharmaceutiques les contenant

Also Published As

Publication number Publication date
FR8146M (fr) 1970-08-17
NL6809794A (fr) 1969-01-21
PH10639A (en) 1977-07-22
GB1240545A (en) 1971-07-28
IE32197B1 (en) 1973-05-16
IE32197L (en) 1969-01-17
GB1240546A (en) 1971-07-28
ES356142A1 (es) 1970-02-16
BE718183A (fr) 1969-01-17
DE1792053B1 (de) 1971-07-29

Similar Documents

Publication Publication Date Title
FR1586125A (fr)
ES485065A1 (es) Un procedimiento para preparar derivados del acido cefalos- poranico
GB1397073A (en) 1,2,4-oxadizoles
GB851287A (en) 5-chlorotoluene-2:4-disulphonamide and alkali metal salts thereof
GB1318478A (en) Cephalexin salts
GB1419121A (en) Heterocyclic-fused triazole derivatives and their use in controlling plant pathogenic organisms
GB1295489A (fr)
GB1363047A (en) Pyrimidine derivative process for its preparation and its use as a medicament
GB1252286A (fr)
ES8402315A1 (es) Procedimiento para preparar derivados de aminoglicosidos.
GB1350878A (en) Coumarin derivatives and production thereof
GB1276061A (en) Tetronic acid derivatives, process for the manufacture thereof, and compositions containing such compounds
GB1314899A (en) Thiosemicarbazones processes for their preparations and compositions incorporating them
GB1512604A (en) Pharmaceutical compositions
GB1125842A (en) Chlorofluorophenyl-nitrophenyl ethers and their use as herbicides
GB1324750A (en) Diacetate pharmaceutical preparations and manufacturing processes
GB1381072A (en) 3-amino-as-triazino-6,5-quinoline and derivatives
GB1252373A (fr)
GB1299037A (en) Dithiocarbamic acid esters
GB1466857A (en) Urea tablets
GB1287497A (en) Basic ether compositions
GB1509778A (en) Pharmaceutical composition and dosage units thereof
GB1125793A (en) Complexes of bismuth and chlorohydroxyquinoline and compositions containing them
GB1214576A (en) Complexes having a prolonged adrenocorticotropic activity and process for their manufacture
GB994350A (en) Improvements in or relating to pteridine compounds and processes for their preparation